USANA Health Sciences Inc (USNA) - Total Assets
Based on the latest financial reports, USANA Health Sciences Inc (USNA) holds total assets worth $738.97 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check USANA Health Sciences Inc (USNA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
USANA Health Sciences Inc - Total Assets Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's total assets have evolved over time, based on quarterly financial data. Check USNA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
USANA Health Sciences Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
USANA Health Sciences Inc's total assets of $738.97 Million consist of 38.8% current assets and 61.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $102.61 Million | 13.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $133.15 Million | 17.9% |
| Goodwill | $137.96 Million | 18.6% |
Asset Composition Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see USANA Health Sciences Inc (USNA) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: USANA Health Sciences Inc's current assets represent 38.8% of total assets in 2025, a decrease from 52.9% in 1995.
- Cash Position: Cash and equivalents constituted 21.3% of total assets in 2025, down from 29.4% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 35.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is goodwill at 18.6% of total assets.
USANA Health Sciences Inc Competitors by Total Assets
Key competitors of USANA Health Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
JBS N.V.
NYSE:JBS
|
USA | $248.34 Billion |
|
MEIJI HLD.UN.ADR 1/4 O.N.
F:3M00
|
Germany | €1.23 Trillion |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
SHE:300765
|
China | CN¥6.21 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
China | CN¥6.24 Billion |
|
Yihai International Holding Ltd
F:YIR
|
Germany | €5.36 Billion |
USANA Health Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.51 | 2.05 | 2.49 |
| Quick Ratio | 1.69 | 1.51 | 1.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $176.99 Million | $144.01 Million | $228.51 Million |
USANA Health Sciences Inc - Advanced Valuation Insights
This section examines the relationship between USANA Health Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.65 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | $742.91 Million |
| Market Capitalization | $348.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values USANA Health Sciences Inc's assets below their book value (0.47x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: USANA Health Sciences Inc's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for USANA Health Sciences Inc (1995–2025)
The table below shows the annual total assets of USANA Health Sciences Inc from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $742.91 Million | -0.71% |
| 2024-12-31 | $748.19 Million | +18.24% |
| 2023-12-31 | $632.76 Million | +6.07% |
| 2022-12-31 | $596.55 Million | +3.26% |
| 2021-12-31 | $577.74 Million | -9.85% |
| 2020-12-31 | $640.89 Million | +23.98% |
| 2019-12-31 | $516.93 Million | -6.77% |
| 2018-12-31 | $554.46 Million | +6.78% |
| 2017-12-31 | $519.27 Million | +10.33% |
| 2016-12-31 | $470.64 Million | +11.20% |
| 2015-12-31 | $423.24 Million | +20.72% |
| 2014-12-31 | $350.58 Million | -4.85% |
| 2013-12-31 | $368.47 Million | +37.82% |
| 2012-12-31 | $267.36 Million | +9.35% |
| 2011-12-31 | $244.50 Million | +19.97% |
| 2010-12-31 | $203.80 Million | +65.10% |
| 2009-12-31 | $123.44 Million | +0.71% |
| 2008-12-31 | $122.57 Million | +12.32% |
| 2007-12-31 | $109.13 Million | +9.13% |
| 2006-12-31 | $100.00 Million | +35.67% |
| 2005-12-31 | $73.71 Million | +2.85% |
| 2004-12-31 | $71.66 Million | +10.04% |
| 2003-12-31 | $65.13 Million | +66.51% |
| 2002-12-31 | $39.11 Million | +10.63% |
| 2001-12-31 | $35.35 Million | -0.39% |
| 2000-12-31 | $35.49 Million | -3.55% |
| 1999-12-31 | $36.80 Million | -8.00% |
| 1998-12-31 | $40.00 Million | +51.52% |
| 1997-12-31 | $26.40 Million | +25.12% |
| 1996-12-31 | $21.10 Million | +106.86% |
| 1995-12-31 | $10.20 Million | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more